FOCIS is the meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides the unique opportunity for innovative thinking and apply ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study.
Continuing Medical Education (CME) *New for 2016*
In the past, FOCIS has made it possible for meeting participants to obtain CME credit for attending the annual meeting. In order to enable all those involved in the research and treatment of immune-mediated diseases to participate in the exchange of ideas that contribute to the forward motion of the field, FOCIS will not offer CME credit for FOCIS 2016. Certificates of attendance will be available upon request.
FOCIS delegates range in specialties including, but not limited to autoimmunity, diabetes, allergy/asthma, transplantation,rheumatology, genetics and neurology, reflecting the diverse and interdisciplinary culture of FOCIS.
FOCIS 2016 offers the opportunity for manufacturers, distributors and suppliers of products that relate to translational immunology to showcase their products/services.
• Complimentary registration to FOCIS 2016 scientific sessions
• Exhibitor suite upgrades available: Hold private meetings with Key Opinion Leaders throughout FOCIS 2016
• Social media promotion connecting exhibitors with the FOCIS audience
The Federation of Clinical Immunology Societies (FOCIS) exists to improve human health through immunology by fostering interdisciplinary approaches to both understand and treat immune-based diseases. Initially established as a cross-disciplinary meeting, FOCIS held its first Annual Meeting in 2001. After two successful consecutive meetings, FOCIS incorporated in 2003 as a 501(c)3 organization. Now in its twelfth year of existence, FOCIS has 53 Member Societies, representing roughly 65,000 clinician scientists. A Federation of this size provides a voice for clinical immunologists and ultimately strives to improve patient care.